IPP Bureau
Lupin launches Atharv ability neuro-rehabilitation centre in Delhi
By IPP Bureau - May 18, 2026
New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches
Alembic Pharma Q4 revenue rises to Rs. 1,848 crore
By IPP Bureau - May 18, 2026
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
Amrutanjan Healthcare expands portfolio in pain management
By IPP Bureau - May 18, 2026
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
Akums Q4 revenue climbs to Rs. 1,158 crore; PAT surges 135%
By IPP Bureau - May 18, 2026
FY26 revenue rises to Rs. 4,359 crore as India’s leading CDMO strengthens global footprint with EU GMP certifications, UK MHRA approval and Europe supplies
Caplin Steriles receives USFDA approval for generic foscarnet sodium injection
By IPP Bureau - May 18, 2026
Antiviral injection addressing CMV and HSV infections had US market sales of nearly $15 million in the last 12 months
Women’s hospital opens in Delhi with $5 million backing
By IPP Bureau - May 18, 2026
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
Mankind launches ‘Act at 30’ campaign to push early heart health screening
By IPP Bureau - May 18, 2026
Nationwide preventive health initiative aims to make cardiovascular screening at age 30 a standard healthcare milestone
Africa CDC warns of regional Ebola spread risk as DRC and Uganda confirm outbreaks
By IPP Bureau - May 18, 2026
Africa CDC activates continental coordination measures; consultations underway on possible Public Health Emergency declaration
Dr Jitendra Singh commends SCTIMST doctors for treating 17,000 patients under AB-PMJAY
By IPP Bureau - May 18, 2026
At the institute's 42nd convocation ceremony, Union Minister described its eight-institution MoU initiative as a unique collaborative effort that brings together premier national institutions to create a synergistic research ecosystem
Experts calls for urgent preventive action as hypertension cases rise
By IPP Bureau - May 18, 2026
Union Minister Prataprao Jadhav terms hypertension a “silent killer”; experts push for early screening, lifestyle correction and wellness-focused healthcare
Surya Hospitals expands advanced women-centric health services
By IPP Bureau - May 18, 2026
New facility ‘Amber Wing’ adds 55 beds and strengthens surgical, cardiac, robotic and preventive care infrastructure for women in Mumbai
WFNS opens doors to industry in landmark Neurosurgery Innovation Pact with Time Med
By IPP Bureau - May 16, 2026
The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers
Dr. Reddy’s launches generic semaglutide in Canada
By IPP Bureau - May 16, 2026
Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada
Lupin receives USFDA nod for Famotidine injection
By IPP Bureau - May 15, 2026
Famotidine Injection USP is a generic version of Pepcid injection to be manufactured at its Nagpur facility for the U.S. market
Indoco Remedies' Baddi plant gets EU GMP approval from Malta Medicines Authority
By IPP Bureau - May 15, 2026
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
